<!DOCTYPE HTML>
<html lang="ru">
<head>
	<meta charset="utf-8">
	<title>Final-task</title>
	<link rel="stylesheet" href="stylesheets/style.css">
</head>
<body>
    <div class="wrapper">
        <header>
            <nav>
                <ul>
                    <li class="nav-tab">
                        <button class="nav-tab-item nav-tab-item-active">Graphics</button>
                    </li>
                    <li class="nav-tab">
                        <button class="nav-tab-item">Calculator</button>
                    </li>
                        <li class="nav-tab">
                            <button class="nav-tab-item">Competitors</button>
                        </li>
                </ul>
            </nav>
        </header>
        <section class="page slider-active">
            <h1 class="graphics-header">Xarelto<sup>®</sup>: An Effective Treatment Option <br> in Your VTE Patients with Cancer<sup>a,8</sup></h1>
            <p class="graphics-name-axis-y">% PATIENTS<sup>b</sup></p>
            <div class="graphics-table">
                <ul class="graphics-axis-number">
                    <li>8 —</li>
                    <li>7 —</li>
                    <li>6 —</li>
                    <li>5 —</li>
                    <li>4 —</li>
                    <li>3 —</li>
                    <li>2 —</li>
                    <li>1 —</li>
                    <li>0</li>
                </ul>
                <p class="graphics-table-title">HR 0.69;<br>95% CI 0.36-1.33</p>
                <div class="graphics-column-blue">
                    <p class="graphics-column-text-top">7.1<br>n=20/281</p>
                    <p class="graphics-column-text-bottom">ENOXAPARIN / VKA</p>
                </div>
                <div class="graphics-column-red">
                    <p class="graphics-column-text-top">5.1<br>n=20/281</p>
                    <p class="graphics-column-text-bottom">XALERTO</p>
                </div>
                <div class="graphics-hr">
                </div>
                <p class="graphics-name-axis-x-for-zero">0</p>
                <p class="graphics-name-axis-x-for-cancer">Cancer</p>
            </div>
            <img class="graphics-person" src="assets/images/graphics/person.png">
            <p class="graphics-footer-text"><sup>a</sup>Xarelto is contraindicated in lesions or conditions, 
                if they are considered to be a significant risk for major<br>
                bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br>
                <sup>b</sup>Outcome: symptomatic, recurrent VTE.</p>
        </section>
        <section class="page">
            <h1 class="graphics-header">Xarelto<sup>®</sup> Estimator of Resources Saved</h1>
            <div class="calculator-block">
                <div class="col-left">
                    <div class="enter-number">
                        <div class="headline-ent-num">
                            <input type="text" placeholder="Enter number of DVT patients here">
                            <input type="button" value="CALCULATE">
                            <input type="button" value="?" class="question">
                        </div>
                        <p class="enter-number-text">Assumptions to estimate calculations: proportion of patients whit DVT contraindicated for Xarelto or LMWH/VKA<sup>1,2</sup> =7.5%<br>
                        <b>Number of patients with DVT - 7.5% = <span>[A]</span></b> Total number of DVT patients eligible for dual LMWH/VKA or Xarelto</p>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>Injections avoided<sup>3-7</sup></p>
                            <input type="text" value="[B + C]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>Injections Avoided = number of LMWH injections received by cancer patients with DVT + LMWH injections received by DVT patients without cancer</p>
                        </div>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>INR clinic visits avoided <sup>3,7,8</sup></p>
                            <input type="text" value="[E]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>INR clinic visits avoided = number of DVT patients eligible for VKA treatment x number of INR monitoring visits per patient</p>
                        </div>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>Nurse visits avoided<sup>9</sup></p>
                            <input type="text" value="[G]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>Nurse assistanse visits avoided = number of non-cancer DVT patients eligible for initial LMWH treatment x proportion of these patients treated by nurses in their own homes x mean number of LMWH injections administered</p>
                        </div>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>Hospital bed days saved<sup>10</sup></p>
                            <input type="text" value="[H]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>Hospital bed days saved = number of eligible DVT patients x proportion of DVT patients hospitalised x number of hospital bed days per DVT patient treated with Xarelto</p>
                        </div>
                    </div>
                </div>
                <div class="col-right">
                    <div class="enter-number">
                        <div class="headline-ent-num">
                            <input type="text" placeholder="Enter number of patients with PE here">
                            <input type="button" value="CALCULATE">
                            <input type="button" value="?" class="question">
                        </div>
                        <p class="enter-number-text">Assumptions to estimate calculations: proportion of patients whit PE contraindicated for Xarelto or LMWH/VKA<sup>1,2</sup> = 15%<br>
                        <b>Number of patients with PE - 15% = <span>[A]</span></b> Total number of PEv patients eligible for dual LMWH/VKA or Xarelto</p>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>Injections avoided<sup>3-6,11</sup></p>
                            <input type="text" value="[B + C]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>Injections Avoided = number of LMWH injections received by cancer patients with PE + LMWH injections received by PE patients without cancer</p>
                        </div>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>INR clinic visits avoided <sup>3,8,11</sup></p>
                            <input type="text" value="[I]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>INR clinic visits avoided = number of PE patients eligible for VKA treatment x number of INR monitoring visits per patient</p>
                        </div>
                    </div>
                    <div class="item-select-calc">
                        <div class="headline">
                            <p>Hospital bed days saved<sup>10</sup></p>
                            <input type="text" value="[J]">
                        </div>
                        <div class="item-select-text">
                            <input type="button" value="+" class="open">
                            <p>Hospital bed days saved = number of eligible PE patients x proportion of PE patients hospitalised x number of hospital bed days per PE patient treated with Xarelto</p>
                        </div>
                    </div>
                </div>
                <div class="calculate-discript">
                    <p class="headline">Combined DVT + PE Resour Saved</p>
                    <div class="item-discript-calc">
                        <p>Injections avoided <sup>3-7,11</sup></p>
                        <p class="formula">[DVT+PE]</p>
                    </div>
                    <div class="item-discript-calc">
                        <p>INR clinic visits avoided<sup>3,7,8,11</sup></p>
                        <p class="formula">[DVT+PE]</p>
                    </div>
                    <div class="item-discript-calc">
                        <p>Nurse visit avoided<sup>9</sup></p>
                        <p class="formula">[DVT]</p>
                    </div>
                    <div class="item-discript-calc">
                        <p>Hospital bed days saved<sup>10</sup></p>
                        <p class="formula">[DVT+PE]</p>
                    </div>
                </div>
            </div>
        </section>
        <section class="page">
            <h1 class="graphics-header competitors-header">Xarelto® DVT Patients Reported Higher Satisfaction<sup>a,16</sup> 
            </h1>
            <div class="competitors-scales">
                <div class="competitors-double-sided-arrow">
                    <p class="competitors-double-sided-arrow-higher">Higher Preference</p>
                    <figure class="competitors-vertical-hr">
                    </figure>
                    <p class="competitors-double-sided-arrow-higher competitors-double-sided-arrow-lower">Lower Preference</p>                
                </div>
                <div class="competitors-scales-block">
                    <div class="competitors-scales-header-hr">                    
                    </div>
                    <div class="competitors-scales-left-bowl">
                        <p class="competitors-scales-left-text">80.8</p>
                    </div> 
                    <div class="competitors-scales-stand">
                        
                    </div> 
                    <div class="competitors-scales-stand-footer">
                        <p>p&lt;0.0001</p>                                       
                    </div>
                    <p class="competitors-scales-footer">Global Satisfaction<sup>b</sup></p>
                    <div class="competitors-scales-left-bowl competitors-scales-right-bowl">
                        <p class="competitors-scales-left-text">72.7</p>
                    </div>             
                </div>
                <div class="competitors-scales-right-link">
                    <div class="competitors-scales-right-top-link">
                        <figure class="competitors-scales-right-link-square">
                            
                        </figure>
                        <button class="competitors-scales-right-link-text">Xarelto (N=702)
                        </button>  
                    </div>
                    <div class="competitors-scales-right-bottom-link">
                        <figure class="competitors-scales-right-link-square competitors-scales-right-link-square-red">
                            
                        </figure>
                        <button class="competitors-scales-right-link-text">Enoxaparin/VKA (N=677)
                        </button>  
                    </div>                   
                </div>
            </div>
            <div class="footer-square-for-competitors-scales">
                <p>TSQM II <br>Global <br>Satisfaction</p>
            </div>
            <p class="graphics-footer-text competitors-scales-footer-text"><sup>a</sup>Xarelto is contraindicated in lesions or conditions, 
                if they are considered to be a significant risk for major<br>
                bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br>
                <sup>b</sup>Outcome: symptomatic, recurrent VTE.
            </p>
        </section>
    </div> 
    <script src="scripts/knockout-3.1.0.js"></script>
    <script type="text/javascript" src="scripts/tab-slider.js"></script>   
</body>
</html>